Vireo Growth (VREOF) EBIT Margin (QoQ) (2020 - 2026)
Vireo Growth (VREOF) EBIT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn |
| 3 | Zoetis | 32.31 Bn | 30.63 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 18.87 Bn | 17.98 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Vireo Growth | 486.94 Mn | 344.64 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,021.00 |
| Dec 31, 2025 | -262.00 |
| Sep 30, 2025 | 508.00 |
| Jun 30, 2025 | -1,236.00 |
| Mar 31, 2025 | 1,153.00 |
| Dec 31, 2024 | -1,867.00 |
| Sep 30, 2024 | -777.00 |
| Jun 30, 2024 | 332.00 |
| Mar 31, 2024 | -250.00 |
| Dec 31, 2023 | -153.00 |
| Sep 30, 2023 | 2,895.00 |
| Jun 30, 2023 | -709.00 |
| Mar 31, 2023 | -175.00 |
| Dec 31, 2022 | 469.00 |
| Sep 30, 2022 | -246.00 |
| Jun 30, 2022 | 5,108.00 |
| Mar 31, 2022 | 1,085.00 |
| Dec 31, 2021 | -2,958.00 |
| Sep 30, 2021 | -808.00 |
| Jun 30, 2021 | 1,391.00 |